S-nitroso-human-albumin: A new therapeutic approach in endotoxic shock

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 7-8, 2009, Pages 501-504

  Jakubowski, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Nitric oxide; S nitroso human serum albumin; Septic shock

Indexed keywords

ALBUMIN; CYCLOOXYGENASE 2; ENDOTOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; NITRIC OXIDE; S NITROSO HUMAN SERUM ALBUMIN; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRY WEIGHT; ENDOTOXEMIA; HYPOTENSION; INFLAMMATION; LUNG EDEMA; LUNG INJURY; MALE; MORTALITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; RAT; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 69249128746     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.755     Document Type: Article

References (22)

1. Jaeschke RZ, Broźek JL, Dellinger RP. 2008 update of international guidelines for the management of severe sepsis and septic shock: should we change our current clinical practice? Pol Arch Med Wewn. 2008; 118: 92-95.
2. Oh-Ishi S, Ishida H, Ueno A. Role of synergistic action of PAF and kinin in bacterial endotoxin-induced hypotention in rats. Adv Exp Med Biol. 1996; 416: 235-238. (Pubitemid 126727509)
3. Thiemermann C. Nitnc oxide and septic shock. Gen Pharmacol. 1997; 29: 159-166.
4. Kirkebøen KA, Strand OA. The role of nitric oxide in sepsis - an overview. Acta Anaesthesiol Scand. 1999; 43: 275-288. (Pubitemid 29109473)
5. Spain DA, Wilson MA, Garrison RN. Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery. 1994; 116: 322-330.
6. Offner PJ, Robertson FM, Pruitt BA Jr. Effects of nitric oxide synthase inhibition on regional blood flow in a porcine model of endotoxic shock. J Trauma. 1995; 39: 338-343.
7. Harbrecht BG, Billiar TR, Stadler J, et al. Nitric oxide synthesis serves to reduce hepatic damage during acute munne endotoxemia. Crit Care Med. 1992; 20: 1568-1574.
8. Łaszlo F, Whittle BJ, Moncada S. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol. 1994; 111: 1309-1315. (Pubitemid 24148806)
9. Park JH, Chang SH, Lee KM, et al. Protective effect of nitric oxide in an endotoxin-induced septic shock. Am J Surg. 1996; 171: 340-345. (Pubitemid 26086703)
10. Gryglewski RJ, Wolkow PP, Uracz W, et al. Protective role of pulmonary nitric oxide in the acute phase of endotoxemia in rats. Circ Res. 1998; 82: 819-827. (Pubitemid 28185850)
11. Cobb JP. Use of nitric oxide synthase inhibitors to treat septic shock: the light has changed from yellow to red. Crit Care Med. 1999; 27: 855-856.
12. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest. 1992; 90: 1718-1725.
13. Laszlo F, Whittle BJ, Moncada S. Attenuation by nitrosothiol NO donors of acute intestinal microvascular dysfunction in the rat. Br J Pharmacol. 1995; 115: 498-502.
14. Yamashita T, Kawashima S, Ohashi Y, et al. Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. Circulation. 2000; 101: 931-937. (Pubitemid 30117890)
15. Feelisch M. The biochemical pathways of nitric oxide formation from notrosovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous solutions. J Cardiovasc Pharmacol. 1991; 17: S25-S33.
16. Bauer JA, Fung HL. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J Pharmacol Exp Ther. 1991; 256: 249-254.
17. Jakubowski A, Maksimovich N, Olszanecki R, et al. S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia. Naunyn Schmiedebergs Arch Pharmacol. 2009; 379: 281-290.
18. Hallström S, Gasser H, Neumayer Ch, et al. S-Nitroso human serum albumin treatment in ischemia/reperfusion injury of skeletal muscle - biochemical aspects. Shock. 1999; Suppl. 12: 4.1
19. Hallström S, Gasser H, et al. S-Nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation. 2002; 105: 3032-3038. (Pubitemid 34693838)
20. Semsroth S, Fellner B, Trescher K, et al: S-nitroso human serum albumin attenuates ischemia/reperfusion injury after cardioplegic arrest in isolated rabbit hearts. J Heart Lung Transplant. 2005; 24: 2226-2234. (Pubitemid 41814750)
21. C Bauer, W Kuntz, F Ohnsmann, et al. The attenuation of hepatic microcirculatory alterations by exogenous substitution of nitric oxide by s-nitroso-human albumin after hemorrhagic shock in the rat. Shock. 2004; 21: 165-169.
22. Munzel T, Daiber A, Ullrich V, et al. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol. 2005; 25: 1551-1557. (Pubitemid 41098921)